semaglutide lone tree co April Special: GLP-1 Weight Loss Program ✨ Featuring Semaglutide & Tirzepatide, our medically guided program helps support Oral Wegovy Approved | Medical

As a defined tetrapeptide, Epithalon is well suited to analytical and mechanistic work

The Timeline: The Phase 3 TRIUMPH-1 trial is nearing its primary completion, expected in May 2026

Semaglutide activates GLP-1 receptors throughout the body, triggering weight loss and metabolic changes that occasionally produce muscle cramping in the legs, shoulders, or abdomen

Clinical studies suggest Zepbound may lead to greater average weight loss for some patients, but the best choice depends on your medical history, goals, side effects, insurance coverage, and response to treatment

Most information comes from experts physiological reasoning, indirect evidence (like what happens to patients fitness levels on GLP-1 therapy), and some basic science studies